Literature DB >> 17137288

Medical case management after laminectomy or craniotomy: do all patients benefit from admission to the intensive care unit?

J A Nitahara1, M Valencia, M A Bronstein.   

Abstract

To define severity of illness to identify most effectively patients for whom admission to the intensive care unit (ICU) is unnecessary, the authors performed a retrospective cost-effectiveness analysis. The authors studied the records of 113 patients who were admitted to the ICU after undergoing laminectomy (or other spinal cord surgery) or craniotomy for removal of neoplasm; the Acute Physiology and Chronic Health Evaluation III prognostic system had identified these patients as having a 10% or less risk of requiring intervention while in the ICU. No patient required active intervention during a mean stay of 3.26 days in the ICU. Combined use of a "step-down" postoperative care unit and ICU can optimize allocation of medical resources while providing high-quality care for some neurosurgical patients who are at low risk of requiring postoperative intervention.

Entities:  

Year:  1998        PMID: 17137288     DOI: 10.3171/foc.1998.5.2.7

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  3 in total

1.  The Utility of Routine Intensive Care Admission for Patients Undergoing Intracranial Neurosurgical Procedures: A Systematic Review.

Authors:  Cesar Cimonari de Almeida; M Dustin Boone; Yosef Laviv; Burkhard S Kasper; Clark C Chen; Ekkehard M Kasper
Journal:  Neurocrit Care       Date:  2018-02       Impact factor: 3.210

2.  Electrolyte orders in the neuroscience intensive care unit: worth the value or waste?

Authors:  Sarah L Clark; Julie L Cunningham; Alejandro A Rabinstein; Eelco F M Wijdicks
Journal:  Neurocrit Care       Date:  2011-04       Impact factor: 3.210

3.  Postoperative intensive care unit requirements after elective craniotomy.

Authors:  Brian W Hanak; Brian P Walcott; Brian V Nahed; Alona Muzikansky; Matthew K Mian; William T Kimberly; William T Curry
Journal:  World Neurosurg       Date:  2012-11-24       Impact factor: 2.104

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.